Anti-tumor action and clinical application of proteasome inhibitor

被引：1
|
作者：
Zhou Yong-ming [2 ]
Yu Mei-xia [2 ]
Long Hui [2 ]
Huang Shi-ang [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Stem Cell Ctr, Wuhan 430022, Peoples R China
[2] Wuhan Univ Sci & Technol, Affiliated Hosp, Dept Hematol, Wuhan 430000, Peoples R China
来源：
CHINESE JOURNAL OF CANCER RESEARCH | 2008年 / 20卷 / 02期
关键词：
proteasome inhibitor; ubiquitin-proteasome pathway; tumor;
D O I：
10.1007/s11670-008-0077-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Ubiquitin-proteasome pathway mediates the degradation of cell protein, and cell cycle, gene translation and expression, antigen presentation and inflammatory development. Proteasome inhibitor can inhibit growth and proliferation of tumor cell, induce apoptosis and reverse multipledrug resistance of tumor cell, increase the sensitivity of other chemotherapeutic drugs and radiotherapy, and is a novel class of potent anti-tumor agents.
引用
收藏
页码：77 / 84
页数：8
相关论文
共 50 条
  • [31] MECHANISM OF ACTION OF ANTHRACYCLINE ANTI-TUMOR ANTIBIOTICS
    SARTIANO, GP
    LYNCH, W
    CLINICAL RESEARCH, 1978, 26 (01): : A60 - A60
  • [32] A NEW APPROACH TO THE SELECTIVITY OF ANTI-TUMOR ACTION
    JONES, GRN
    BRITISH JOURNAL OF CANCER, 1982, 45 (04) : 638 - 638
  • [33] PREDICTION OF THE SPECTRUM OF ACTION FOR ANTI-TUMOR PREPARATIONS
    KARAIVANOVA, MK
    KASABOV, NK
    STKHRISTOV, I
    EKSPERIMENTALNAYA ONKOLOGIYA, 1983, 5 (01): : 51 - 54
  • [34] MECHANISM OF THE LOCAL ANTI-TUMOR ACTION OF INFLAMMATION
    ALEXANDER, P
    PARR, IB
    JACKSON, LE
    TRANSPLANTATION PROCEEDINGS, 1981, 13 (04) : 1929 - 1931
  • [35] ISOPRINOSINE INCREASES THE ANTI-TUMOR ACTION OF INTERFERON
    CERUTTI, I
    CHANY, C
    SCHLUMBERGER, JF
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1979, 1 (01): : 59 - 63
  • [36] ANTI-TUMOR ACTION OF ALKYL-LYSOPHOSPHOLIPIDS
    BERDEL, WE
    BAUSERT, WRE
    FINK, U
    RASTETTER, J
    MUNDER, PG
    ANTICANCER RESEARCH, 1981, 1 (06) : 345 - 352
  • [37] THE MODE OF ACTION OF THE ANTI-TUMOR DRUG BOUVARDIN, AN INHIBITOR OF PROTEIN-SYNTHESIS IN EUKARYOTIC CELLS
    ZALACAIN, M
    ZAERA, E
    VAZQUEZ, D
    JIMENEZ, A
    FEBS LETTERS, 1982, 148 (01) : 95 - 97
  • [38] Boosting autophagy in anti-tumor proteasome inhibition-mediated cardiotoxicity
    Papanagnou, Eleni-Dimitra
    Gumeni, Sentiljana
    Trougakos, Ioannis P.
    AGING-US, 2023, 15 (09): : 3226 - 3227
  • [39] Pharmacokinetics, pharmacodynamics and anti-tumor efficacy of PR-171, a novel inhibitor of the 20S proteasome.
    Kirk, CJ
    Bennett, MK
    Buchholz, TJ
    Demo, SD
    Ho, MN
    Jiang, J
    Laidig, GJ
    Lewis, ER
    Shenk, KD
    Smyth, MS
    Sun, CM
    Vallone, MK
    Woo, TM
    Molineaux, CJ
    BLOOD, 2005, 106 (11) : 181A - 181A
  • [40] The proteasome inhibitor MLN9708 has strong anti-tumor activity in the murine bone marrow compartment in vivo
    Bannerman, Bret
    Zhang, Mengkun
    Lee, Edmund
    Fitzgerald, Mike
    Silva, Matthew
    Manfredi, Mark
    Kupperman, Erik
    CANCER RESEARCH, 2009, 69
12345